The Effect of Ozone on Salivary Flow in Patients With Xerostomia and Hyposalivation After Radiotherapy (OZONEXEROSTOMI) (ozonexerostomi)
The Effect of Ozone Therapy on Salivary Flow and Quality of Life in Patients With Xerostomia and Hyposalivation After Head and Neck Radiotherapy
Patients who underwent head and neck radiotherapy and developed xerostomia and/or hyposalivation will be selected. The patients will be randomly assigned into two groups, defined as control and treatment.
All patients will complete the xerostomia-related quality of life questionnaires, XeQoLS (Xerostomia Quality of Life Scale) and OHIP (Oral Health Impact Profile). This qualitative assessment will be repeated 1 week after the 6th application and 1 week after the 12th application (T0, T6, and T12).
The quantitative assessment will be carried out through the collection of unstimulated and stimulated saliva at the same time points (T0, T6, and T12).
Patients will undergo 12 sessions of ozone therapy, once a week, in gaseous form, at a concentration of 10 µg/mL (micrograms per milliliter), applied directly into the major salivary glands.
The gas will be administered as follows:
- Parotid glands: two distinct points per gland, 1 mL at each point.
- Submandibular glands: one point per gland, 1 mL per point at 10 µg/mL.
- Sublingual glands: one point per gland, 1 mL per point at 10 µg/mL. The ozone generator equipment will be supplied with medical oxygen (99.5% purity), Dental model, Philozon company.
Disposable syringes will be Terumo, 10 mL, and the needle will be BD, 30/13 mm.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Sergio B Macedo, PhD
- Número de telefone: +5561981276050
- E-mail: bruzadelli@unb.br
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Patients who have undergone head and neck radiotherapy
- Patient who have developed xerostomia
- Patient who have developed hyposalivation
Exclusion Criteria:
- Patients with active malignant disease
- Patients who do not agree to sign the informed consent form
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: ozone therapy
Ozone gas will be applied as follows:
The ozone generator (Dental model, Philozon, Brazil) will be supplied with medical oxygen (99.5% purity). |
Experimental: Ozone Therapy Ozone gas will be applied as follows:
The ozone generator (Dental model, Philozon, Brazil) will be supplied with medical oxygen (99.5% purity). |
|
Sem intervenção: no treatment
Patients in the control group will not receive any treatment but will complete the xerostomia-related quality of life questionnaires and undergo salivary flow assessment at T0, T6, and T12
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Salivary flow
Prazo: Time 0 weeks
|
The assessment of unstimulated salivary flow will be conducted according to the technique described by Kogawa et al., 2016. The patient will receive a sterile vial, keep the body slightly leaning forward, place the vial touching the lower lip, and allow saliva to flow into the vial spontaneously for 5 minutes. The unit of measurement will be in microliters. |
Time 0 weeks
|
|
Salivary flow
Prazo: time 6 weeks
|
The assessment of unstimulated salivary flow will be conducted according to the technique described by Kogawa et al., 2016. The patient will receive a sterile vial, keep the body slightly leaning forward, place the vial touching the lower lip, and allow saliva to flow into the vial spontaneously for 5 minutes. The unit of measurement will be in microliters. |
time 6 weeks
|
|
Salivary Flow
Prazo: 12 week
|
The assessment of unstimulated salivary flow will be conducted according to the technique described by Kogawa et al., 2016.
The patient will receive a sterile vial, keep the body slightly leaning forward, place the vial touching the lower lip, and allow saliva to flow into the vial spontaneously for 5 minutes.
The unit of measurement will be in microliters.
|
12 week
|
|
Salivary flow
Prazo: Time 0 weeks
|
The assessment of stimulated salivary flow will be conducted according to the technique described by Kogawa et al., 2016.
The patient will receive a sterile vial, keep the body slightly leaning forward, place the vial touching the lower lip, and allow saliva to flow into the vial spontaneously for 5 minutes.
Stimulated saliva will be collected using the same procedure, preceded by chewing a piece of silicone for 1 minute.
The unit of measurement will be in microliters.
|
Time 0 weeks
|
|
Salivary flow
Prazo: Time 6 weeks
|
The assessment of stimulated salivary flow will be conducted according to the technique described by Kogawa et al., 2016.
The patient will receive a sterile vial, keep the body slightly leaning forward, place the vial touching the lower lip, and allow saliva to flow into the vial spontaneously for 5 minutes.
Stimulated saliva will be collected using the same procedure, preceded by chewing a piece of silicone for 1 minute.
The unit of measurement will be in microliters.
|
Time 6 weeks
|
|
Salivary flow
Prazo: Time 12 weeks
|
The assessment of stimulated salivary flow will be conducted according to the technique described by Kogawa et al., 2016.
The patient will receive a sterile vial, keep the body slightly leaning forward, place the vial touching the lower lip, and allow saliva to flow into the vial spontaneously for 5 minutes.
Stimulated saliva will be collected using the same procedure, preceded by chewing a piece of silicone for 1 minute.
The unit of measurement will be in microliters.
|
Time 12 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Xerostomia-Related Quality of Life Scale (XeQoLS)
Prazo: time 0 weeks
|
The Xerostomia-Related Quality of Life Scale (XeQoLS) consists of 15 items, each scored from 0 to 4 according to the severity of xerostomia impact.
The final score is calculated as the mean of all items, resulting in a total score ranging from 0 to 4, where 0 indicates no impact and 4 indicates maximum impact.
Higher scores indicate worse xerostomia-related quality of life.
|
time 0 weeks
|
|
Xerostomia-Related Quality of Life Scale (XeQoLS)
Prazo: time 6 weeks
|
The Xerostomia-Related Quality of Life Scale (XeQoLS) consists of 15 items, each scored from 0 to 4 according to the severity of xerostomia impact.
The final score is calculated as the mean of all items, resulting in a total score ranging from 0 to 4, where 0 indicates no impact and 4 indicates maximum impact.
Higher scores indicate worse xerostomia-related quality of life.
|
time 6 weeks
|
|
Xerostomia-Related Quality of Life Scale (XeQoLS)
Prazo: time 12 weeks
|
The Xerostomia-Related Quality of Life Scale (XeQoLS) consists of 15 items, each scored from 0 to 4 according to the severity of xerostomia impact.
The final score is calculated as the mean of all items, resulting in a total score ranging from 0 to 4, where 0 indicates no impact and 4 indicates maximum impact.
Higher scores indicate worse xerostomia-related quality of life.
|
time 12 weeks
|
|
Oral Health Impact Profile-14 (OHIP-14)
Prazo: time 0 weeks
|
The Oral Health Impact Profile-14 (OHIP-14) is a validated questionnaire consisting of 14 items assessing the impact of oral health on quality of life. Each item is scored from 0 to 4 based on frequency of impact (0 = never, 1 = hardly ever, 2 = occasionally, 3 = fairly often, 4 = very often). The total score is calculated as the sum of all items, ranging from 0 to 56, with higher scores indicating worse oral health-related quality of life. |
time 0 weeks
|
|
Oral Health Impact Profile-14 (OHIP-14)
Prazo: time 6 weeks
|
The Oral Health Impact Profile-14 (OHIP-14) is a validated questionnaire consisting of 14 items assessing the impact of oral health on quality of life. Each item is scored from 0 to 4 based on frequency of impact (0 = never, 1 = hardly ever, 2 = occasionally, 3 = fairly often, 4 = very often). The total score is calculated as the sum of all items, ranging from 0 to 56, with higher scores indicating worse oral health-related quality of life. |
time 6 weeks
|
|
Oral Health Impact Profile-14 (OHIP-14)
Prazo: time 12 weeks
|
The Oral Health Impact Profile-14 (OHIP-14) is a validated questionnaire consisting of 14 items assessing the impact of oral health on quality of life. Each item is scored from 0 to 4 based on frequency of impact (0 = never, 1 = hardly ever, 2 = occasionally, 3 = fairly often, 4 = very often). The total score is calculated as the sum of all items, ranging from 0 to 56, with higher scores indicating worse oral health-related quality of life. |
time 12 weeks
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 66681722.6.0000.0030
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .